Canopy Growth (CGC)
(Delayed Data from NSDQ)
$4.86 USD
+0.27 (5.88%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $4.86 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.86 USD
+0.27 (5.88%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $4.86 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
Zacks News
Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $48.87, marking a +0.43% move from the previous day.
Pot Stocks & ETF: Risks and Rewards
by Neena Mishra
Here is what investors need to know about risks and rewards of investing in the emerging marijuana industry.
Top Wall Street Stories of the Third Quarter
by Sweta Killa
We discuss some of the events that dominated the headlines in the third quarter and influenced the market.
Has the Earnings Picture Started Weakening?
by Sheraz Mian
A big part of the positive revisions over the last two quarters was due to the direct impact of the tax cuts. With that issue now behind us, the revisions trend appears to be moving back to how it has behaved over the last few years.
Canopy Growth Corporation (CGC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Canopy Growth Corporation (CGC) closed at $52.70, marking a +0.46% move from the previous day.
Wall Street's Reefer Madness, Micron Earnings, & More Stock News
by Ryan McQueeney
Ryan McQueeney and Maddy Johnson discuss the performance of Netflix and other streaming services at the Emmys. The team also chat about the alleged criminal probe facing Elon Musk and Tesla. Later, they discuss marijuana stocks and recap Micron's latest earnings report.
Is Goldilocks Market Coming?
by Zacks Equity Research
Is Goldilocks Market Coming?
How Much Longer for the Goldilocks Market?
by Mark Vickery
Investors who've been around the block a few times tend to look for something around the corner that threatens to stick a pin in this ever-expanding balloon.
Cannabis Company Tilray's (TLRY) Shares Up 856% Since July
by Zacks Equity Research
Tilray (TLRY) inks an import deal with the U.S. Drug Enforcement Administration for a trial on neurological movement disorder.
Know How Beverage Stocks Will Gain From Shift to Marijuana
by Rajani Lohia
Cannabis-infused drinks have emerged as an attractive alternative to the problems of the players in the U.S. beverage space, given the health benefits it offers.
Tesla Bull Sells (and Buys Again?) & Dow Rallies Near Highs | Free Lunch
by Ryan McQueeney
Ryan McQueeney highlights the Dow's rally toward all-time highs on the back of strength from financial stocks. He also touches on news related to marijuana producers and reported activist interest in casino giant MGM. Later, the host calls Brian Bolan, a noted Tesla bull, to discuss a major shift in his sentiment for the electric car company.
Marijuana Stocks Soar Again As Wall Street Eyes U.S. Imports
by Ryan McQueeney
Shares of several popular Canadian marijuana producers--including Tilray (TLRY), Canopy Growth (CGC), and Cronos Group (CRON)--were surging once again on Wednesday as Wall Street grows ever-more bullish on the prospects of legalization and U.S. imports.
Why Marijuana Stocks and ETF are Soaring
by Neena Mishra
Pot stocks are hot but also very volatile, here is what investors need to know
Will Disruptive Technology Play a Role in the Marijuana Industry?
by Ryan McQueeney
Ryan McQueeney discusses the intersection of disruptive technology and the budding marijuana industry, ultimately concluding that investors should remember what they've learned about investing in other forms of new tech as it becomes a bigger factor in the cannabis business.
Company News For Sep 18, 2018
by Zacks Equity Research
Companies In The News are: AMZN,CGC,KO,MDP
Is Coca-Cola's Cannabis Venture a Solution to Its Problems?
by Zacks Equity Research
Coca-Cola (KO) explores the cannabis-infused drinks market to combat the fading popularity of sugary carbonated sodas.
Marijuana Stocks and ETF: What Investors Need to Know
by Neena Mishra
Pot stocks are hot but also very volatile, here is what investors need to know.
ETFs & Stocks to Tap Marijuana Boom
by Sweta Killa
Investors seeking to tap the ongoing green rush may consider these ETFs and stocks.
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed at $51.05 in the latest trading session, marking a -0.31% move from the prior day.
Canopy Growth Corporation (CGC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Canopy Growth Corporation (CGC) closed the most recent trading day at $51.90, moving -1.53% from the previous trading session.
Top and Flop ETFs of August
by Sanghamitra Saha
Inside the top and worst performing ETFs of August.
Top ETF Stories of August
by Sanghamitra Saha
Inside the eye-catching ETF events of August.
5 Best Stocks of the Top ETF of August
by Sweta Killa
Cannabis-related ETFMG Alternative Harvest ETF (MJ) is the best-performing ETF of August, gaining 22.5% and attracting $22 million in AUM.
Canopy Growth (CGC) Jumps: Stock Rises 7.4%
by Zacks Equity Research
Canopy Growth (CGC) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
What Investors Need to Know About Investing In Marijuana Stocks
by Benjamin Rains
Marijuana has come a long way since California legalized cannabis for medicinal use back in 1996. Today, the industry and marijuana look to be on the cusp of unprecedented acceptance, with major international giants investing billions into publicly traded cannabis companies. So let's take a look at what investors need to know about the marijuana industry and how to invest in the future of pot.